Health · 1 sources covering this

Trump administration asks Supreme Court to allow transgender medical care restrictions in prison

The Trump administration asked the Supreme Court on Monday to let it enforce, for now, restrictions on gender-affirming care in federal prison.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·2h ago
Trump administration asks Supreme Court to allow transgender medical care restrictions in prison
The Trump administration asked the Supreme Court on Monday to let it enforce, for now, restrictions on gender-affirming care in federal prison.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/bcb971cdee5f1e258b131ada8db6c8afdfaf4450"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Trump administration asks Supreme Court to allow transgender medical care restrictions in prison"></iframe>

Trump administration asks Supreme Court to allow transgender medical care restrictions in prison

How 1 sources are covering this

Trump administration asks Supreme Court to allow transgender medical care restrictions in prison

More from Health

STAT+: It really is bleak out there, and list prices matter

STAT+: AbbVie wins FDA nod for Parkinson’s pill

STAT+: Pharmalittle: We’re reading about GLP-1s becoming lifestyle drugs, a setback for Merck and Daiichi, and more

Trump uses ‘contested’ power to cut more funding to HHS

Reader

Trust & legal

Across the network

How 1 sources are covering this

Trump administration asks Supreme Court to allow transgender medical care restrictions in prison

More from Health

STAT+: It really is bleak out there, and list prices matter

STAT+: AbbVie wins FDA nod for Parkinson&#8217;s pill

STAT+: Pharmalittle: We&#8217;re reading about GLP-1s becoming lifestyle drugs, a setback for Merck and Daiichi, and more

Trump uses ‘contested’ power to cut more funding to HHS

Reader

Trust & legal

Across the network

STAT+: AbbVie wins FDA nod for Parkinson’s pill

STAT+: Pharmalittle: We’re reading about GLP-1s becoming lifestyle drugs, a setback for Merck and Daiichi, and more